BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 10891498)

  • 1. MCG10, a novel p53 target gene that encodes a KH domain RNA-binding protein, is capable of inducing apoptosis and cell cycle arrest in G(2)-M.
    Zhu J; Chen X
    Mol Cell Biol; 2000 Aug; 20(15):5602-18. PubMed ID: 10891498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociation between cell cycle arrest and apoptosis can occur in Li-Fraumeni cells heterozygous for p53 gene mutations.
    Delia D; Goi K; Mizutani S; Yamada T; Aiello A; Fontanella E; Lamorte G; Iwata S; Ishioka C; Krajewski S; Reed JC; Pierotti MA
    Oncogene; 1997 May; 14(18):2137-47. PubMed ID: 9174049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of the nucleic-acid-binding activity of KH domains. Different properties of different domains.
    Dejgaard K; Leffers H
    Eur J Biochem; 1996 Oct; 241(2):425-31. PubMed ID: 8917439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3p21.3 tumor suppressor gene H37/Luca15/RBM5 inhibits growth of human lung cancer cells through cell cycle arrest and apoptosis.
    Oh JJ; Razfar A; Delgado I; Reed RA; Malkina A; Boctor B; Slamon DJ
    Cancer Res; 2006 Apr; 66(7):3419-27. PubMed ID: 16585163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct interaction with and activation of p53 by SMAR1 retards cell-cycle progression at G2/M phase and delays tumor growth in mice.
    Kaul R; Mukherjee S; Ahmed F; Bhat MK; Chhipa R; Galande S; Chattopadhyay S
    Int J Cancer; 2003 Feb; 103(5):606-15. PubMed ID: 12494467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p63alpha and DeltaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes.
    Dohn M; Zhang S; Chen X
    Oncogene; 2001 May; 20(25):3193-205. PubMed ID: 11423969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of two major cellular poly(rC)-binding human proteins, each containing three K-homologous (KH) domains.
    Leffers H; Dejgaard K; Celis JE
    Eur J Biochem; 1995 Jun; 230(2):447-53. PubMed ID: 7607214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimized RNA targets of two closely related triple KH domain proteins, heterogeneous nuclear ribonucleoprotein K and alphaCP-2KL, suggest Distinct modes of RNA recognition.
    Thisted T; Lyakhov DL; Liebhaber SA
    J Biol Chem; 2001 May; 276(20):17484-96. PubMed ID: 11278705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cyclin-dependent kinase inhibitor p21 is regulated by RNA-binding protein PCBP4 via mRNA stability.
    Scoumanne A; Cho SJ; Zhang J; Chen X
    Nucleic Acids Res; 2011 Jan; 39(1):213-24. PubMed ID: 20817677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SHP-2 phosphatase regulates DNA damage-induced apoptosis and G2/M arrest in catalytically dependent and independent manners, respectively.
    Yuan L; Yu WM; Xu M; Qu CK
    J Biol Chem; 2005 Dec; 280(52):42701-6. PubMed ID: 16260787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the G2/M transition by p53.
    Taylor WR; Stark GR
    Oncogene; 2001 Apr; 20(15):1803-15. PubMed ID: 11313928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RGC32, a novel p53-inducible gene, is located on centrosomes during mitosis and results in G2/M arrest.
    Saigusa K; Imoto I; Tanikawa C; Aoyagi M; Ohno K; Nakamura Y; Inazawa J
    Oncogene; 2007 Feb; 26(8):1110-21. PubMed ID: 17146433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mice deficient in poly(C)-binding protein 4 are susceptible to spontaneous tumors through increased expression of ZFP871 that targets p53 for degradation.
    Yan W; Scoumanne A; Jung YS; Xu E; Zhang J; Zhang Y; Ren C; Sun P; Chen X
    Genes Dev; 2016 Mar; 30(5):522-34. PubMed ID: 26915821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PA26, a novel target of the p53 tumor suppressor and member of the GADD family of DNA damage and growth arrest inducible genes.
    Velasco-Miguel S; Buckbinder L; Jean P; Gelbert L; Talbott R; Laidlaw J; Seizinger B; Kley N
    Oncogene; 1999 Jan; 18(1):127-37. PubMed ID: 9926927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of cellular target genes by p53 devoid of the PXXP motifs with impaired apoptotic activity.
    Zhu J; Jiang J; Zhou W; Zhu K; Chen X
    Oncogene; 1999 Mar; 18(12):2149-55. PubMed ID: 10321740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ribosomal protein S27-like, a p53-inducible modulator of cell fate in response to genotoxic stress.
    Li J; Tan J; Zhuang L; Banerjee B; Yang X; Chau JF; Lee PL; Hande MP; Li B; Yu Q
    Cancer Res; 2007 Dec; 67(23):11317-26. PubMed ID: 18056458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of fourteen novel putative and nine known target genes of the p53 family.
    Chen X; Liu G; Zhu J; Jiang J; Nozell S; Willis A
    Cancer Biol Ther; 2003; 2(1):55-62. PubMed ID: 12673118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel p53 functional domain that is necessary for efficient growth suppression.
    Walker KK; Levine AJ
    Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15335-40. PubMed ID: 8986812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sam68 functions as a transcriptional coactivator of the p53 tumor suppressor.
    Li N; Richard S
    Nucleic Acids Res; 2016 Oct; 44(18):8726-8741. PubMed ID: 27365047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function.
    Kokontis JM; Wagner AJ; O'Leary M; Liao S; Hay N
    Oncogene; 2001 Feb; 20(6):659-68. PubMed ID: 11313999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.